Background: Many patients with liver malignancies are not candidates for resection, and
systemic therapies are often not effective. Radioembolization (RE) is an alternative treatment …

Abstract Background Yttrium-90 (90 Y) positron emission tomography with integrated
computed tomography (PET/CT) represents a technological leap from 90 Y bremsstrahlung …

Abstract Yttrium-90 radioembolization (90 Y-RE) is a well-established therapy for the
treatment of hepatocellular carcinoma (HCC) and also of metastatic liver deposits from other …

Radioembolization is a locoregional transarterial therapy that combines radionuclide and
micron-sized beads to deliver radiation internally to the target tumors based on the arterial …

Transarterial radioembolization (TARE) is an intra-arterial radiation therapy for patients with
primary and secondary hepatic malignancies, and its role outside the liver is evolving. The …

As a relatively safe outpatient procedure, radioembolization can potentially be used to treat
any type of tumor within the liver, primary or metastatic. The safety and effectiveness of …

While initially described and now accepted as treatment for primary and secondary
malignancies in the liver, radioembolization therapy has expanded to include treatment for …

The management of chest tumors and their sequelae has been an uncommon indication for
transarterial embolization (TAE). More recently, vascular embolization has been increasingly …

Transarterial radioembolization (TARE) with yttrium-90 microspheres has emerged as an
effective therapy for the treatment of both primary and metastatic hepatic lesions. It has been …

Modern advances in interventional radiology and nuclear medicine may now allow for safe
and effective 90 Y radioembolization to sites other than the liver. A general theory of …